The CGM Royal Rumble – 4 systems face off, one will win…
Back in early October the CGM Royal Rumble kicked off. Four CGM systems, located in their manufacturer recommended locations on the body and using their […]
CGM
Abbott’s #FreestyleLibre2. Announced today at #EASD2018 – more questions than answers…
Abbott’s Freestyle Libre 2. Newly announced at EASD2018. Introducing bluetooth connectivity and real-time alarms.
Yet another new CGM system – with a MARD of 8.67%… Welcome the POCTech CT-100
***Updated following clarification from the UK Distributor*** Whilst I recently tested and reported back on the Medtrum A6 CGM system, it’s not the only newcomer […]
A month with Medtrum’s A6 CGM
With two sensors now used and a month of data captured, I felt it was time for further feedback on the newest CGM system on […]
Medtrum A6 CGM – A week (or two) in the life
After the initial couple of days with the Medtrum, and the data that was produced, I thought it would be a good idea to provide […]
The Medtrum A6 CGM. Initial impressions on performance…
Following the earlier article on what you get when you buy a Medtrum A6 CGM, let me precipitate this piece by mentioning that it contains […]
Disruption in CGM land… Can Medtrum take Dexcom’s crown?
Back in August 2016, I met Medtrum at a JDRF Discovery day. They seemed to be offering a new set of options in the CGM […]
The real cost of Time in Range – what it takes to replace Hba1C #ATTD2018
Anyone watching the Twitter feed for the Advanced Technologies and Treatments for Diabetes 2018 conference can’t fail to have noticed that, once again, the answer […]
Are we living in the past? Good reasons why achieving the NICE Target Hba1C with the available NHS tools is tough…
As many people (but let’s face it, not all) are aware, the NICE target for Hba1C level is 6.5% as this is the point at […]
What’s the best CGM solution? A simple question with a complex answer…
Over the past couple of months, I’ve seen this question asked multiple times on many fora. Facebook, email lists and forums have all seen people […]